Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Zinof 200 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Zinof 200

Approved

STANDARD

Zinof 200

Sydenham Laboratories, Inc.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 6a780d9f444adac0
Company: Sydenham Laboratories, Inc.
Type: Standard

Approval Details

Approval Id: 6a780d9f444adac0
Drug Approval Philippines Name: Zinof 200
Product Name: Zinof 200
Registration Number: DRP-3511
Brand Name: Zinof 200
Generic Name: Fenofibrate
Dosage Form: Capsule
Dosage Strength: 200 mg
Manufacturer: Sydenham Laboratories, Inc.
Distributor: Bell-Kenz Pharma Inc.
Issuance Date: 27 December 2021
Expiry Date: 19 January 2027
Pharmacologic Category: Antihyperlipidemic
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

6a780d9f444adac0

Type

Standard

Back to Philippines FDA Approvals